Spirometric Values of Patients with Chronic Obstructive Pulmonary Disease in Dr. Hasan Sadikin General Hospital Bandung

Christopher Rinaldi; Rudolf Andean; Irma Ruslina Defi

doi:10.15850/amj.v7n2.1687

Spirometric Values of Patients with Chronic Obstructive Pulmonary Disease in Dr. Hasan Sadikin General Hospital Bandung

Christopher Rinaldi, Rudolf Andean, Irma Ruslina Defi

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a frequently underdiagnosed disease. Definitive COPD has been diagnosed using spirometry to evaluate pulmonary function. This study aimed to explore the spirometric values of COPD patients to aid in the diagnosis of COPD.

Methods: A descriptive study was conducted in Dr. Hasan Sadikin General Hospital Bandung from October to November 2015. Data on patients diagnosed with COPD, aged 40 to 60 years old, were collected during the year 2014 prior to ethical clearance. Spirometry values consisted of forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio were taken from the medical records.

Results: Sixty-eight COPD patients, consisting of 48 males and 20 females, were included of with most were classified as moderate COPD. The FEV1 was 49.72±17.79, whereas the FVC was 55.90 (range 22.80–96.03), and the FEV1/FVC ratio was 0.70±0.12. Most patients were classified into moderate COPD who had FEV1 between 50 and 80% of normal as GOLD 2 standard.

Conclusions: Even though patients seem to have no symptoms, spirometric values may show a silent insufficient lung function affecting patients’ daily life.

Keywords

Chronic obstructive pulmonary disease, COPD, FEV1, FVC, spirometry

Full Text:

PDF

References

Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30(5):993–1013.

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD (updated 2015). Fontana: GOLD [internet] 2015 [Cited 2015 October 12]. Available from: http://www.goldcopd.org.

Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–32.

Rodriguez-Rodriguez P, Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, Puente-Maestu L, Miguel-Diez JD. Prevalence of physical disability in patients with chronic obstructive pulmonary disease and associated risk factors. COPD. 2013;10(5):611–7.

Lim S, Lam DC-L, Muttalif AR, Yunus F, Wongtim S, Lan LTT,et. al. Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med. 2015;14(1):4.

Fromer L. Diagnosing and treating COPD: understanding the challenges and finding solutions. Intl J Gen Med. 2011;4:729–39.

Bailey KL. The Importance of the Assessment of Pulmonary Function in COPD. Med Clin North Am. 2012;96(4):745–52.

Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res. 2013;162(4):208–18.

Sørheim I, Johannessen A, Gulsvik A, Bakke P, Silverman E, DeMeo D. Gender differences in COPD: are women more susceptible to smoking effects than men?. Thorax. 2010;65(6):480–85.

Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B,et. al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA. 2014;311(2):183–92.

Öberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377(9760):139–46.

Schermer TRJ, Smeele IJM, Thoonen BPA, Lucas AEM, Grootens JG, van Boxem TJ,et. al. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J. 2008;32(4):945–52.

Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1(3):253–60.

Jarad N. Chronic obstructive pulmonary disease (COPD) and old age?. Chron Respir Dis. 2011;8(2):143–51.

Martinez FD. The origins of asthma and chronic obstructive pulmonary disease in early life. Proc Am Thorac Soc. 2009;6(3):272–7.

Hoesein FAM, Zanen P, Sachs AP, Verheij TJ, Lammers JW, Broekhuizen BD. Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre- or post-dilator values?. COPD. 2012;9(4):338–43.

Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest. 2007;131(2):349–55.

Lusuardi M, De Benedetto F, Paggiaro P, Sanguinetti CM, Brazzola G, Ferri P, et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and COPD: a comparative evaluation Italian study. Chest. 2006;129(4):844–52.

DOI: https://doi.org/10.15850/amj.v7n2.1687